Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Viralytics Limited (VLA)
  6. Company Announcements

Viralytics Limited (ASX: VLA) - Announcements

DELISTED - Current share price for VLA : $1.745

ASX company news and announcements for Viralytics Limited (VLA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Viralytics Limited (VLA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Viralytics Limited (VLA), please use our Company Announcements tool to search across all ASX-listed companies.

Intelligent Investor free trial for buy hold sell stock recommendations

Latest company announcements for Viralytics Limited (VLA)

Search all Announcements
Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg		 Gain/Loss
- Appendix 4C - quarterly 25 Jan 2008 3:35PM $0.070 $1.745 $1.745 risen by 2,392.86%
- Placement 19 Dec 2007 9:47AM $0.088 $1.745 $1.745 risen by 1,882.95%
- Trading Halt 17 Dec 2007 9:50AM n/a $1.745 $1.745 n/a
- Share Purchase Plan 30 Nov 2007 4:43PM $0.085 $1.745 $1.745 risen by 1,952.94%
- Phase I IV trial patient selection 28 Nov 2007 11:59AM $0.091 $1.745 $1.745 risen by 1,817.58%
- Response to ASX Share Price Query 12 Nov 2007 10:14AM $0.110 $1.745 $1.745 risen by 1,486.36%
- Appendix 4C - quarterly 29 Oct 2007 10:05AM $0.063 $1.745 $1.745 risen by 2,669.84%
- Clincial trial progresses to 10 fold higher dosing level 5 Sep 2007 11:02AM $0.080 $1.745 $1.745 risen by 2,081.25%
- Annual Report and appendix 4e 31 Aug 2007 11:32AM $0.074 $1.745 $1.745 risen by 2,258.11%
- Appendix 4C - quarterly 31 Jul 2007 12:04PM $0.080 $1.745 $1.745 risen by 2,081.25%
- Response to ASX Query 11 May 2007 9:04AM $0.125 $1.745 $1.745 risen by 1,296%
- International Research Collaboration in Human Brain Cancer 26 Apr 2007 9:56AM $0.081 $1.745 $1.745 risen by 2,054.32%
- Commitments Test Entity - Third Quarter Report 20 Apr 2007 12:44PM $0.077 $1.745 $1.745 risen by 2,166.23%
- Half Yearly Report/Half Year Accounts 27 Feb 2007 8:33AM $0.100 $1.745 $1.745 risen by 1,645%
- Ethics Committee Approval - Breast/Prostate & Melanoma Trial 12 Jan 2007 9:36AM $0.130 $1.745 $1.745 risen by 1,242.31%
- Commitments Test Entity - Second Quarter Report 10 Jan 2007 12:52PM $0.120 $1.745 $1.745 risen by 1,354.17%

326 - 341 of 341 results

Page 14 of 14

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.